BRIEF-BTG to buy targeted therapies arm of Nordion

LONDON Thu May 23, 2013 2:14am EDT

LONDON May 23 (Reuters) - BTG PLC : * Proposed acquisition of therasphere * To buy the targeted therapies division of nordion, for approximately US$200

million (£133 million) * Balance funded by part of the net proceeds of a placing of up to 32.8 million

new ordinary shares * Deal creates a leader in interventional oncology

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.